Analyst Update: Cal-Maine Foods, Tesoro, Incyte

Analysts revised their ratings and price targets on Cal-Maine Foods Inc (CALM), Tesoro Corporation (TSO), and Incyte Corporation (INCY)

May 9, 2016 at 3:14 PM
facebook twitter linkedin


Analysts are weighing in on egg seller Cal-Maine Foods Inc (NASDAQ:CALM), oil stock Tesoro Corporation (NYSE:TSO), and biopharmaceutical company Incyte Corporation (NASDAQ:INCY). Here's a quick roundup of today's brokerage notes on CALM, TSO, and INCY.

  • CALM has dropped 5.8% at $48.68, after D.A. Davidson downgraded CALM to "underperform" and cut its price target to $45 from $55. The egg distributor has had a rocky six months, with its 200-day moving average capping most rebound attempts since early December. Short sellers have been especially keen on Cal-Maine Foods Inc, and 55.3% of the stock's float is currently short sold, which would take 28.4 days of trading, at CALM's average daily volume, to cover.

  • TSO is down 2.8% at $75.74, due to an energy slide and a pair of negative analyst notes. Specifically, Credit Suisse and Goldman Sachs cut the stock's price target to $100 and $99, respectively. Since exploring annual lows in February, TSO attempted a rebound, but was halted at its 20-week moving average. Tesoro Corporation's Schaeffer's put/call open interest ratio (SOIR) of 0.35 sits only in the ninth percentile of annual readings, suggesting short-term options traders have been especially call-biased lately, perhaps hoping for a rebound.

  • INCY is up 4.4% at $73.92, after announcing plans to acquire Ariad Pharmaceuticals, Inc.'s (NASDAQ:ARIA) European arm. The news has overshadowed post-earnings price-target cuts from Piper Jaffray and BMO, to $91 and $76, respectively. INCY is down 34.8% since the beginning of the year, after stopping key drug studies in the first quarter. However, INCY's 50-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE) and NASDAQ OMX PHLX (PHLX) sits at the highest point in a year, at 242.83 calls bought to open for every put. In other words, it appears option buyers have been betting on a surge for INCY.

For other stocks in analysts' crosshairs, read Analyst Upgrades: Tesla Motors Inc, Depomed Inc, and Transocean Inc, and Analyst Downgrades: Apple Inc., Berkshire Hathaway Inc., and Intel Corporation.

 

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Best stocks for October and worst stocks for October
 


 


 
Special Offers from Schaeffer's Trading Partners